Indacaterol and Glycopyrrolate and Panitumumab Intravenous
Determining the interaction of Indacaterol and Glycopyrrolate and Panitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: Glycopyrrolate and indacaterol (inhalation)
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indacaterol and Glycopyrrolate-Panixine
- Indacaterol and Glycopyrrolate-Panixine DisperDose
- Indacaterol and Glycopyrrolate-Panlor
- Indacaterol and Glycopyrrolate-Panlor Tablet
- Indacaterol and Glycopyrrolate-Panlor Tablets
- Indacaterol and Glycopyrrolate-Panlor-DC
- Panitumumab Intravenous-Indacaterol and glycopyrrolate Inhalation
- Panitumumab Intravenous-Indacaterol inhalation
- Panitumumab Intravenous-Indacaterol Maleate
- Panitumumab Intravenous-Indapamide
- Panitumumab Intravenous-Inderal
- Panitumumab Intravenous-Inderal Intravenous